Last edition
News about
Beckman Coulter Launches RUO Immunoassay Test
Access BD-Tau, along with Beckman Coulter Diagnostics's expanding portfolio of neuro-degenerative disease RUO assays, is available for use on the ground-breaking DxI 9000 Immunoassay Analyzer and Access 2 Analyzer.
AstraZeneca India Gets NPPA Show-Cause Notice Over Alleged Overcharging of Symbicort Turbuhaler
AstraZeneca Pharma India has received a show cause notice from the National Pharmaceutical Pricing Authority (NPPA) for allegedly overcharging on its Symbicort Turbuhaler Inhalation Powder (60 doses).
UK Risks Losing Global Life Sciences Edge as Pharma Investment Decline, ABPI Warns
The UK risks losing its world-leading position in life sciences as investment in pharmaceutical research and development continues to fall behind international competitors, according to a new report from the Association of the British Pharmaceutical Industry (ABPI).
Modular Medical Completes MODD1 Clinical Study, Advances Toward Next-Gen Pivot Pump Launch
US-based insulin delivery technology company Modular Medical has announced the successful completion of a clinical study with its MODD1 pump.
Neon Parody Labs Launches GENOMIRATHEON
Neon Parody Labs has developed a platform that converts gene activity into verifiable legal and financial records by detecting electrical pulses and light emissions from gene expression.
Merck, known as MSD outside the United States and Canada, has reported positive results from its Phase 3 STRIDE-13 trial evaluating Capvaxive, its 21-valent pneumococcal conjugate vaccine.
New GST Rates: DCGI Orders Medical Device Makers to Update MRP Within 3 Months
The Central Drugs Standard Control Organization (CDSCO) has directed manufacturers and importers of Class C and D medical devices to update their inventories with revised MRP reflecting the newly reduced 5 percent Goods and Services Tax (GST).
Otsuka Acquires CAN10 from Cantargia
The deal transfers Cantargia’s CAN10 antibody programme to Otsuka, with Cantargia securing an upfront payment of USD 33 Million.
Implantica Expands Manufacturing of RefluxStop Device to Meet Anticipated US Demand
Implantica AG, a medtech company pioneering advanced technology inside the body, has unveiled its strategy to manufacture 10,000 RefluxStop devices in preparation for substantial demand from the United States, following FDA pre-market approval.
Tata Elxsi Opens Global Radiology Tech Hub for Bayer
The centre will serve as a global innovation hub, combining Tata Elxsi’s engineering expertise with India’s healthcare ecosystem to accelerate Bayer’s radiology solutions across key markets, including the US and EU.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy